Timothy Babinchak
Phoenixville Hospital(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Use and Resistance, Bacterial Identification and Susceptibility Testing, Antimicrobial Resistance in Staphylococcus
Most-Cited Works
- → A Randomized and Blinded Multicenter Trial of High‐Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects(2003)493 cited
- → The Efficacy and Safety of Tigecycline in the Treatment of Skin and Skin‐Structure Infections: Results of 2 Double‐Blind Phase 3 Comparison Studies with Vancomycin‐Aztreonam(2005)415 cited
- → The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra‐Abdominal Infections: Analysis of Pooled Clinical Trial Data(2005)382 cited
- → Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza(2012)292 cited
- → Tigecycline: an update(2013)174 cited
- → A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744](2005)153 cited
- → Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study(2008)136 cited
- → Intensification and Stimulation Therapy for Human Immunodeficiency Virus Type 1 Reservoirs in Infected Persons Receiving Virally Suppressive Highly Active Antiretroviral Therapy(2002)127 cited
- → Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Skin and Skin-Structure Infections(2007)111 cited
- → Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Intra-Abdominal Infections(2007)103 cited